Clobetasol propionate 0.05% ointment
Clobetasol propionate 0.05% ointment is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus
Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus
A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin
Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis
Clinical Trials (7)
Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus
Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus
A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin
Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis
Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus
Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7